We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of the glucose monitoring system, which helps people to manage their diabetes. Its products and services include Continuous glucose monitoring system, Sensor, Smart transmitter, a... Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of the glucose monitoring system, which helps people to manage their diabetes. Its products and services include Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States. Show more
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems...
The first fully implantable continuous glucose monitors can now be integrated with insulin pumps as part of an automated insulin delivery system Senseonics Holdings, Inc. (NYSE American: SENS), a...
SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS PR Newswire PARSIPPANY, N.J., March 12, 2024 Eligible individuals in the U.S. will pay $99 out of pocket for...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0458 | 9.79050876443 | 0.4678 | 0.5264 | 0.4419 | 2482966 | 0.49789947 | CS |
4 | 0.0097 | 1.92498511609 | 0.5039 | 0.53 | 0.3838 | 2381812 | 0.45428955 | CS |
12 | -0.0537 | -9.46589106293 | 0.5673 | 0.75 | 0.3838 | 2599568 | 0.56328557 | CS |
26 | 0.0021 | 0.410557184751 | 0.5115 | 0.75 | 0.3838 | 2462873 | 0.57500761 | CS |
52 | -0.1057 | -17.0676570321 | 0.6193 | 1.05 | 0.3838 | 4032869 | 0.66579901 | CS |
156 | -1.3964 | -73.109947644 | 1.91 | 4.58 | 0.3838 | 7452584 | 2.32773016 | CS |
260 | -1.8164 | -77.9570815451 | 2.33 | 5.56 | 0.3497 | 8305773 | 2.37109656 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions